10 results on '"Shirakawa Y"'
Search Results
2. Role of vagal afferents in hypotension induced by venous air embolism
- Author
-
M. Aibiki, Osamu Umegaki, K. Seki, K. Ogli, Ogura S, Shirakawa Y, and Honda K
- Subjects
Time Factors ,Baroreceptor ,Physiology ,medicine.medical_treatment ,Vagotomy ,Baroreflex ,Air embolism ,Veins ,Physiology (medical) ,medicine ,Animals ,Embolism, Air ,Neurons, Afferent ,business.industry ,Central venous pressure ,Vagus Nerve ,Sinus of Valsalva ,medicine.disease ,Denervation ,Vagus nerve ,Autonomic nervous system ,Blood pressure ,Anesthesia ,Rabbits ,Hypotension ,business - Abstract
To evaluate the role of the autonomic nervous system in the development of hypotension during air embolism, we studied the effects of an intravenous bolus injection of air (0.5 ml/kg) on mean blood pressure (MBP), central venous pressure (CVP), and renal nerve activity (RNA) in urethan-anesthetized rabbits of three groups: animals with an intact neuraxis (intact group; n = 5), cervical-vagotomized animals (vagotomy group; n = 5), and sinoaortic-denervated animals (SAD group; n = 5). In the intact group, despite a significant decrease in MBP at 10 s after air injection, RNA did not increase from the preinjection level. This response of RNA was associated with a significant increase in CVP and lasted for 20 s after the injection. Vagotomized animals, however, exhibited a significant augmentation in RNA in response to a drop in MBP at 10 s after the injection. In the SAD group, profound declines in both MBP and RNA were observed at 10 s after the injection of air. Animals in these two groups showed remarkable increases in CVP. At 5 min after the air administration, MBP in the vagotomy group was significantly higher than that in the intact group. All animals in the SAD group died within 5 min of the injection. These results indicate that during hypotension induced by air injection, sympathetic activation through arterial baroreceptors may be depressed by vagal afferents emanating from cardiopulmonary receptors; the results also suggest that the arterial baroreceptor nerves may be required to overcome the lethal events that should occur during venous air embolism.
- Published
- 1994
- Full Text
- View/download PDF
3. Pseudoprogression following concurrent temozolomide and radiotherapy in a patient with glioblastoma: findings on functional imaging techniques
- Author
-
Shirakawa, Y., Yoshiura, T., Hiwatashi, A., Koji Yamashita, Kamano, H., Shioyama, Y., Abe, K., Amano, T., Nakamizo, A., Yoshimoto, K., Honda, H., Torisu, R., and Suzuki, S.
- Subjects
Magnetic resonance (MR) imaging ,Chemoradiotherapy ,Middle Aged ,Combined Modality Therapy ,Magnetic Resonance Imaging ,Dacarbazine ,Pseudoprogression ,Positron emission tomography (PET) ,Positron-Emission Tomography ,Disease Progression ,Temozolomide ,Humans ,Female ,Glioblastoma ,Antineoplastic Agents, Alkylating - Abstract
Concurrent temozolomide (TMZ) and radiotherapy became the new standard of care for patients diagnosed with glioblastoma multiforme (GBM). Recently, there has been an increasing awareness of progressive and enhancing lesions on MR images immediately after treatment. These lesions may be a treatment effect, so-called pseudoprogression. We experienced one case pathologically and clinically diagnosed as pseudoprogression. The lesion showed a high apparent diffusion coefficient on diffusion-weighted imaging, low blood volume on perfusion imaging, and low uptake of 18F-fluorodeoxyglucose on positron emission tomography. The lesion was pathologically diagnosed as pseudoprogression after additional surgical resection., 膠芽腫に対するtemozolomide(TMZ)を用いた化学放射線治療後に生じたpseudoprogressionの機能画像所見を報告する. 症例 : 失語を主訴とする54歳の女性の左頭頂はにMRI でリング状増強を示す腫瘤が指摘された. 当院脳外科において部分切除され, 病理学的に膠芽腫と診断された. TMZ を用いた術後化学放射線治療が行われたが, 治療後のMRI で残存腫瘍の画像上の増大がみとめられた. このとき拡散強調画像では, 腫瘤内のみかけ上の拡散係数(apparent diffusion coefficient,ADC)は正常白質より高く, 灌流画像では血液量が正常白質より低かった. また, positron-emission tomography(PET)では, 正常白質よりわずかに高い程度の糖代謝をみとめた. 追加切除が行われ, 病理学的には腫瘍細胞の増生はなく, 浮腫状のgliosis と壊死, および放射線治療により分裂能を失ったglioma 細胞がみとめられた. これらの臨床経過, 画像および病理所見から, pseudoprogression と診断された. 考察 : 拡散強調画像での高いADC, 灌流画像での低い血液量, およびPETでの比較的低い糖代謝は, 腫瘍の活発な増殖の欠如を反映していると考えられた. これらの機能画像の, pseudoprogressionと真の腫瘍増大との鑑別における有用性が示唆された.
- Published
- 2011
4. Thyrotropin-releasing hormone produces different hemodynamic effects in vegetative and brain-dead patients
- Author
-
M. Aibiki, Shirakawa Y, Umegaki O, K. Ogli, Ogura S, K. Seki, and Uefuji T
- Subjects
Adult ,Male ,endocrine system ,medicine.medical_specialty ,Sympathetic nervous system ,Brain Death ,Baroreceptor ,Central nervous system ,Thyrotropin-releasing hormone ,Blood Pressure ,Heart Rate ,Internal medicine ,medicine ,Humans ,Pharmacology (medical) ,Coma ,Thyrotropin-Releasing Hormone ,Aged ,Pharmacology ,business.industry ,Hemodynamics ,Middle Aged ,Spinal cord ,medicine.anatomical_structure ,Endocrinology ,Blood pressure ,Reflex ,Female ,Neurology (clinical) ,Brainstem ,business ,Brain Stem - Abstract
To define a mechanism for the pressor effects of thyrotropin-releasing hormone (TRH), we evaluated changes in mean blood pressure (MBP) when a synthetic form of TRH (0.1 mg/kg, i.v.) was injected into two types of comatose patients: vegetative and brain dead. The patients in the vegetative group (n = 7, age 58 +/- 6) retained spontaneous respiration and brainstem function, whereas the brain-dead (BD) patients (n = 7, age 68 +/- 4) lacked these functions. In the vegetative group, TRH caused significant increases in MBP (from 91 +/- 8 mm Hg to 110 +/- 10 mm Hg) at 2 min after the injection [p < 0.05, analysis of variance (ANOVA) with a Scheffe F-test]. In contrast, five of the seven BD patient showed no alterations in the measured parameter in response to the TRH injection. However, the remaining two BD patients, who had spinal reflexes, exhibited an elevation in MBP. In such BD patients, baroreceptor reflex function was virtually absent, suggesting that the blood pressure regulation mediating through the baroreceptor reflex system might be abolished. These results indicate that in comatose patients, the hemodynamic effects of TRH may differ depending on impairments in the central nervous system; the results support previous reports indicating a mediation of the central sympathetic nervous system in the development of pressor effects of TRH. Furthermore, because brain-dead patients with spinal reflexes showed hypertensive responses to TRH, there is a possibility that these responses may have resulted from an activation of TRH receptors in the spinal cord.
- Published
- 1993
5. Hypotensive and bradycardiac responses to thyrotropin-releasing hormone in a comatose patient
- Author
-
M. Aibiki, Ogura S, Hisao Komatsu, Yamaguchi Y, Shirakawa Y, and K. Ogli
- Subjects
Bradycardia ,Nervous system ,endocrine system ,medicine.medical_specialty ,Sympathetic nervous system ,Baroreceptor ,Thyrotropin-releasing hormone ,Blood Pressure ,Electrocardiography ,Heart Rate ,Internal medicine ,medicine ,Humans ,Pharmacology (medical) ,Coma ,Thyrotropin-Releasing Hormone ,Pharmacology ,business.industry ,Middle Aged ,Endocrinology ,medicine.anatomical_structure ,Blood pressure ,Anesthesia ,Female ,Neurology (clinical) ,medicine.symptom ,Hypotension ,business ,hormones, hormone substitutes, and hormone antagonists ,Hormone - Abstract
Summary A 46-year-old female motorcyclist, who suffered injuries to the brain stem in a traffic accident, showed hypotensive and bradycardiac responses to thyrotropin-releasing hormone (TRH) given to counter consciousness disturbance. The cardiodepressive responses to TRH were reduced with i.v. pretreatment with atropine sulfate, suggesting an involvement of the vagal nervous system in the development of the responses. Furthermore, this patient had complicated impairments in the sympathetic nervous system, which were revealed by the results of testing baroreceptor reflex sensitivity to pharmacological alterations in blood pressure. We thus speculate that the hypotensive and bradycardiac effects of TRH observed in this patient may result from derangements of the sympathetic nervous system caused by the injuries. This case report is believed to be a novel description of the cardiodepressive effects of TRH.
- Published
- 1992
6. Recurrence after Endoscopic Curative Resection of Mucosal Gastric Cancer Associated with an Adjacent Neoplastic Precursor Lesion
- Author
-
Satoru Kikuchi, Kagawa S, Ohara T, Kubota T, Kuwada K, Kagawa T, Kuroda S, Shirakawa Y, Nishizaki M, and Fujiwara T
- Subjects
endoscopic submucosal dissection ,dysplasia-like atypia ,early gastric cancer ,local recurrence - Abstract
A 69-year-old man underwent endoscopic submucosal dissection (ESD) for early gastric cancer (EGC) at the lesser curvature in the angle of stomach. Histological examination revealed tub1, pM, ly0, v0, pLM(-), pVM(-), and the resection was considered curative. The scar after ESD was followed by esophagogastroduodenoscopy (EGD) and biopsy. Twenty months later, EGD showed an ulcerative lesion in the vicinity of the ESD scar, and histological examination of the biopsy specimen showed adenocarcinoma. A distal gastrectomy with lymph node dissection was then performed. Postoperative pathology showed tub1, pM, pN0, ly0, v0, and Stage 1A. Skip lesions were seen in the specimen resected by ESD, and the histological review confirmed so-called “dysplasia-like atypia” (DLA) between the lesions. It has been reported recently that in DLA, the dysplasia-like change involves only the bases of the pits, without upper pit or surface epithelium involvement, and it is said that the rate of DLA is higher in gastric cancer patients. We speculated that a precancerous lesion close to the resected cancer developed into a local recurrence.
7. SPICE-NIRS microbeam: a focused vertical system for proton irradiation of a single cell for radiobiological research
- Author
-
Teruaki Konishi, Oikawa, M., Suya, N., Ishikawa, T., Maeda, T., Kobayashi, A., Shiomi, N., Kodama, K., Hamano, T., Homma-Takeda, S., Isono, M., Hieda, K., Uchihori, Y., and Shirakawa, Y.
- Abstract
The Single Particle Irradiation system to Cell (SPICE) facility at the National Institute of Radiological Sciences (NIRS) is a focused vertical microbeam system designed to irradiate the nuclei of adhesive mammalian cells with a defined number of 3.4 MeV protons. The approximately 2-micrometer diameter proton beam is focused with a magnetic quadrupole triplet lens and traverses the cells contained in dishes from bottom to top. All procedures for irradiation, such as cell image capturing, cell recognition and position calculation, are automated. The most distinctive characteristic of the system is its stability and high throughput; i.e. 3,000 cells in a 5 mm x 5 mm area in a single dish can be routinely irradiated by the 2-micrometer beam within 15 min (the maximum irradiation speed is 400 cells per minute). The number of protons can be set as low as one, at a precision measured by CR-39 detectors to be 99.0%. A variety of targeting modes such as fractional population targeting mode, multi-position targeting mode for nucleus irradiation and cytoplasm targeting mode are available. As an example of multi-position targeting irradiation of mammalian cells, five fluorescent spots in a cell nucleus were demonstrated using the gamma-H2AX immune-staining technique. The SPICE performance modes described in this paper are in routine use. SPICE is a joint-use research facility of NIRS and its beam times are distributed for collaborative research.
8. Prone-position thoracoscopic ligation of the thoracic duct for chyle leak following radical neck dissection in a patient with a right aortic arch
- Author
-
Shirakawa, Y., Noma, K., Ohara, T., Kashima, H., Maeda, N., Tanabe, S., Shunsuke Kagawa, and Fujiwara, T.
- Subjects
Esophagectomy ,Male ,chyle leak ,prone position ,Humans ,Neck Dissection ,thoracoscopy ,Aorta, Thoracic ,Chyle ,Ligation ,Aged ,thoracic duct - Abstract
A chyle leak can occur as a complication after neck or chest surgery. Such a leak prolongs the hospital stay and is sometimes life-threatening. The treatment options are conservative management, interventional radiologic embolization, and surgery. Thoracoscopic ligation of the thoracic duct has emerged as a promising and definitive treatment. The case of a 65-year-old Japanese male patient with a rare congenital right aortic arch (typeⅢB1 of Edward's classification) and a severe chyle leak that occurred after a total pharyngolaryngo-esophagectomy (TPLE) is described. The chyle leak was successfully managed by thoracoscopic ligation of the thoracic duct via a left-side approach with the patient in the prone position.
9. Genetic alterations of candidate tumor suppressor ING1 in human esophageal squamous cell cancer
- Author
-
Chen L, Matsubara N, Yoshino T, Takeshi Nagasaka, Hoshizima N, Shirakawa Y, Naomoto Y, Isozaki H, Riabowol K, and Tanaka N
- Subjects
Aged, 80 and over ,Male ,Esophageal Neoplasms ,Tumor Suppressor Proteins ,Intracellular Signaling Peptides and Proteins ,Mutation, Missense ,Loss of Heterozygosity ,Nuclear Proteins ,Proteins ,Cell Cycle Proteins ,Middle Aged ,Immunohistochemistry ,DNA-Binding Proteins ,Protein Biosynthesis ,Carcinoma, Squamous Cell ,Humans ,Female ,Genes, Tumor Suppressor ,RNA, Messenger ,Inhibitor of Growth Protein 1 ,Aged - Abstract
Overexpression of ING1, a candidate tumor suppressor gene, efficiently blocks cell growth or induces apoptosis in different experimental systems. ING1 maps to chromosome 13q33-34, and because loss of the terminal region of chromosome 13q has been implicated in esophageal squamous cell cancer (ESCC), we examined ESCC for genetic alterations of ING1. Among 31 informative cases of ESCC, 58.9% of the tumors showed allelic loss at chromosome 13q33-34, and we detected four tumor-specific missense nucleotide changes. These alterations were found within the PHD finger domain and nuclear localization motif of the ING1 and may be functionally involved in the development of ESCC. Because immunohistochemical study revealed that all of the ESCC samples showed loss of ING1 protein expression, genetic or epigenetic alterations that abrogate the normal function of ING1 may contribute to esophageal squamous cell carcinogenesis.
10. Therapeutic potential of targeting cancer-associated fibroblasts in esophageal cancer
- Author
-
Noma, K., Kashima, H., Ninomiya, T., Katsube, R., Watanabe, S., Ohara, T., Tazawa, H., Shunsuke Kagawa, Shirakawa, Y., and Fujiwara, T.
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.